Synopsis of recent research by authors named "Courtney L James"
- Courtney L James's research primarily focuses on pharmacogenomics and its implications in neuroprotection therapies, particularly highlighting the use of nimodipine in patients with aneurysmal subarachnoid hemorrhage (aSAH), where standard dosing may need adjustments based on genetic factors related to drug metabolism.
- Recent findings emphasize the potential for dose reductions of nimodipine to optimize neurologic outcomes, suggesting that pharmacogenomic considerations could lead to more tailored treatment strategies in managing aSAH.
- Additionally, James has explored complications associated with nimodipine, including cases of junctional bradycardia in elderly patients, underscoring the importance of monitoring adverse effects and understanding individual patient responses to medication during treatment for subarachnoid hemorrhage.